BioShares Biotechnology Financial Diagnostics

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 32.56  1.3  4.16%

BioShares Biotechnology Clinical Trials diagnostics interface makes it easy to digest most current publicly released information about BioShares Biotechnology as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis BioShares Biotechnology price relationship with some important fundamental indicators such as market cap and management efficiency.
BioShares Biotechnology is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Virtus ETF Solutions LLC. The fund has 86 constituents with avarage daily trading value of 19.2 K. The fund charges 0.79 percent management fee with total expences of 0.79 percent of total asset. The fund holds all of assets under management (AUM) in equities. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. For more info on BBC please contact the company at 888-383-0553.

Sector Exposure (%)

Investment Allocations (%)

 % of ETF 

BioShares Biotechnology Alerts

On December 20, 2017 BioShares Biotechnology paid $ 0.297 per share dividend to its current shareholders
Latest headline from BioShares Biotechnology Clinical Trials Rises 2.51 percent for Jan 17
The fund holds all of its assets under management (AUM) in equities

Market Capitalization

The company currently falls under '' category with total capitalization of 0.

Technical Drivers

BioShares Biotechnology Clinical Trials shows Downside Deviation of 2.04, Risk Adjusted Performance of 0.2018 and Mean Deviation of 1.42. BioShares Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity future prices. In plain English you can use this information to find out if the entity will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for BioShares Biotechnology Clinical Trials which can be compared to its rivals. Please confirm BioShares Biotechnology Maximum Drawdown, Semi Variance and the relationship between Jensen Alpha and Potential Upside to decide if BioShares Biotechnology is priced correctly providing market reflects its regular price of 32.56 per share.

BioShares Biotechnology Price Movement Analysis

Time Period
Deviations up
Deviations down
MA Type
  Portfolio Optimization    
Execute Study
The output start index for this execution was five with a total number of output elements of twelve. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioShares Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioShares Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.